CCL25 and inflammatory bowel disease: In the context of CCR9-dependent pDC distribution in mice, we successfully confirmed the upregulation of CCL25 in human small intestines from patients with Crohn’s disease (Supplemental Figure 4), which is consistent with a previous report on the abundance of gut-tropic pDCs in patients with inflammatory bowel disease (35).